The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
By James A. Driscoll, S. Brody, Marin Kollef. Drugs, 2012
863 citations recorded by the source corpus.
Subfields: Critical Care and Intensive Care Medicine, Molecular Biology, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/b116a68e03e1eb4d47d3b381aade86446152af99
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Molecular Medicine
Citations in the corpus
- Efflux-Mediated Drug Resistance in Bacteria: an Update (2009, background): “[1,208] A Bmr3-overproducing mutant selected by puromcyin exhibited the increased stability of bmr3 transcripts andMDR.”
- Healthcare-associated infections, medical devices and biofilms: risk, tolerance and control. (2015, background): “In addition, the N-(3-oxo-dodecanoyl)-L-homoserine QS molecule has been reported to increase Pseudomomas aeruginosa biofilm virulence and repress host immune responses (Driscoll et al., 2007).”